ZA918423B - Proteins and nucleic acids. - Google Patents

Proteins and nucleic acids.

Info

Publication number
ZA918423B
ZA918423B ZA918423A ZA918423A ZA918423B ZA 918423 B ZA918423 B ZA 918423B ZA 918423 A ZA918423 A ZA 918423A ZA 918423 A ZA918423 A ZA 918423A ZA 918423 B ZA918423 B ZA 918423B
Authority
ZA
South Africa
Prior art keywords
proteins
nucleic acids
nucleic
acids
Prior art date
Application number
ZA918423A
Inventor
Keith Martyn Dawson
Richard Mark Edwards
Anthony Fallon
Original Assignee
British Bio Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Bio Technology filed Critical British Bio Technology
Publication of ZA918423B publication Critical patent/ZA918423B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA918423A 1990-10-24 1991-10-22 Proteins and nucleic acids. ZA918423B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909023149A GB9023149D0 (en) 1990-10-24 1990-10-24 Proteins and nucleic acids

Publications (1)

Publication Number Publication Date
ZA918423B true ZA918423B (en) 1993-04-22

Family

ID=10684292

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA918423A ZA918423B (en) 1990-10-24 1991-10-22 Proteins and nucleic acids.

Country Status (7)

Country Link
AU (1) AU8769791A (en)
GB (1) GB9023149D0 (en)
IE (1) IE913675A1 (en)
NZ (1) NZ240307A (en)
PT (1) PT99293A (en)
WO (1) WO1992007874A1 (en)
ZA (1) ZA918423B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1124964A (en) * 1993-06-11 1996-06-19 默里尔药物公司 Trifunctional antithrombin and antiplatelet peptides
US5708160A (en) * 1995-04-26 1998-01-13 The National Research Council HSP-60 genomic locus and primers for species identification
GB9705787D0 (en) 1997-03-20 1997-05-07 Thrombosis Res Inst Modified dendroaspins
EP2187955A2 (en) * 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Therapeutic use of peptide yglf and combination with kvlpvpq
US10533044B2 (en) 2014-01-06 2020-01-14 The General Hospital Corporation Integrin Antagonists
US11643439B2 (en) 2015-08-05 2023-05-09 Shaanxi Micot Technology Limited Company Multi-target compound with anticoagulation and antiplatelet activity, preparation method therefor, and use thereof
CN113402583B (en) * 2021-06-19 2023-03-21 江西农业大学 QGK tripeptide and application thereof
CN113933377A (en) * 2021-09-28 2022-01-14 深圳湾实验室 Compound and mass spectrum standard substance and calibration substance thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8516421D0 (en) * 1985-06-28 1985-07-31 Biotechnology Interface Ltd Fibronectins
GB8628398D0 (en) * 1986-11-27 1986-12-31 Central Blood Lab Authority Pharmaceutically-active conjugates
ATE103332T1 (en) * 1987-10-09 1994-04-15 Monsanto Co MODIFIED TISSUE PLASMINOGEN ACTIVATOR.
EP0333356A3 (en) * 1988-03-04 1990-12-19 Biogen, Inc. Hirudin peptides
FR2628429B1 (en) * 1988-03-08 1990-12-28 Transgene Sa HIRUDINE VARIANTS, USES THEREOF AND PROCESSES FOR OBTAINING THEM
DE3831714A1 (en) * 1988-09-17 1990-03-22 Basf Ag TPA-SIMILAR POLYPEPTIDES, THEIR PREPARATION AND USE
JP2878341B2 (en) * 1989-03-03 1999-04-05 学校法人藤田学園 Artificial functional polypeptide

Also Published As

Publication number Publication date
GB9023149D0 (en) 1990-12-05
PT99293A (en) 1992-09-30
NZ240307A (en) 1993-03-26
IE913675A1 (en) 1992-05-22
AU8769791A (en) 1992-05-26
WO1992007874A1 (en) 1992-05-14

Similar Documents

Publication Publication Date Title
PL310677A1 (en) Pharmaceutical agents based on nucleic acids
EP0578819A4 (en) Icam-related protein.
SG91794G (en) Protein hydrolysis.
ZA918423B (en) Proteins and nucleic acids.
ZA894800B (en) Proteins and nucleic acids
GB9314802D0 (en) Modified proteins
GB9003621D0 (en) Protein factor
GB9322723D0 (en) Determining nucleic acids
GB8817161D0 (en) Modified proteins
ZA912183B (en) Protein phosphatase inhibitor-1 gene and expression
ZA921892B (en) Proteins and nucleic acids
GB8921227D0 (en) Antibodies and proteins
GB8816095D0 (en) Protein
GB9116325D0 (en) Proteins and nucleic acids
GB9310227D0 (en) Protein and dna
GB9202401D0 (en) Proteins and nucleic acids
GB9512092D0 (en) Proteins and nucleic acids
GB9217881D0 (en) Protein and nucleic acids
GB9408064D0 (en) Nucleic acids
GB9022760D0 (en) Dna sequence and polypeptide
GB9314175D0 (en) Obtaining nucleic acids
GB9126359D0 (en) Nucleic acids
GB9112796D0 (en) Nucleic acids
GB9318010D0 (en) Nucleic acids
GB9017728D0 (en) Proteins